These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 4790711)

  • 1. Inhibition of lymphocyte cytotoxicity for human colon carcinoma by treatment with solubilized tumour membrane fractions.
    Baldwin RW; Embleton MJ; Price MR
    Int J Cancer; 1973 Jul; 12(1):84-92. PubMed ID: 4790711
    [No Abstract]   [Full Text] [Related]  

  • 2. Significance of tumour associated antigens on human colonic carcinomata.
    Embleton MJ
    Br J Cancer Suppl; 1973 Aug; 1():142-52. PubMed ID: 4804277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cell mediated cytotoxicity against human colon carcinomata by papain-solubilized tumour membrane extracts.
    Embleton MJ; Price MR
    Br J Cancer; 1973 Jul; 28(1):79. PubMed ID: 4724618
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell-mediated and humoral immune reactions to human tumours.
    Baldwin RW; Embleton MJ; Jones JS; Langman MJ
    Int J Cancer; 1973 Jul; 12(1):73-83. PubMed ID: 4790710
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor-specific cellular cytotoxicity to human sarcomas: evidence for a cell-mediated host immune response to a common sarcoma cell-surface antigen.
    Cohen AM; Ketcham AS; Morton DL
    J Natl Cancer Inst; 1973 Mar; 50(3):585-9. PubMed ID: 4513520
    [No Abstract]   [Full Text] [Related]  

  • 6. Lymphocyte anergy in patients with carcinoma.
    Nind AP; Nairn RC; Rolland JM; Guli EP; Hughes ES
    Br J Cancer; 1973 Aug; 28(2):108-17. PubMed ID: 4581078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-associated and embryonic antigens in soluble fractions of a chemically-induced rat colon carcinoma.
    Steele G; Sjögren HO; Price MR
    Int J Cancer; 1975 Jul; 16(1):33-51. PubMed ID: 1176194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and humoral immunity against human malignant melanoma.
    Fossati G; Colnaghi MI; Porta GD; Cascinelli N; Veronesi U
    Int J Cancer; 1971 Sep; 8(2):344-50. PubMed ID: 4943925
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment of cell-mediated immunity to human tumor-associated antigens.
    Baldwin RW; Embeton MJ
    Int Rev Exp Pathol; 1977; 17():49-95. PubMed ID: 849883
    [No Abstract]   [Full Text] [Related]  

  • 10. [The characterization of tumour-associated membrane-bound antigens and their implementation in the treatment of malignant melanoma (author's transl)].
    Kokoschka EM
    Wien Klin Wochenschr Suppl; 1979; 97():3-32. PubMed ID: 106559
    [No Abstract]   [Full Text] [Related]  

  • 11. K cell mediated lysis of cultured colon carcinoma and urinary bladder carcinoma cells induced by monospecific antisera against carcinoembryonic antigen (CEA) and two CEA-related normal glycoproteins.
    Hammarström S; Troye M; Wahlund G; Svenberg T; Perlmann P
    Int J Cancer; 1977 Jun; 19(6):756-66. PubMed ID: 873641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on specificity of cell-mediated immunity to human tumors.
    Takasugi M; Mickey MR; Terasaki PI
    J Natl Cancer Inst; 1974 Dec; 53(6):1527-38. PubMed ID: 4140237
    [No Abstract]   [Full Text] [Related]  

  • 13. Newer concepts of cancer of the colon and rectum: cellular immunity to human colonic carcinomas.
    Hellström I; Hellström KE
    Dis Colon Rectum; 1972; 15(2):100-5. PubMed ID: 4554736
    [No Abstract]   [Full Text] [Related]  

  • 14. Further definition by cytotoxicity tests of cell surface antigens of human sarcomas in culture.
    Bloom ET
    Cancer Res; 1972 May; 32(5):960-7. PubMed ID: 4502173
    [No Abstract]   [Full Text] [Related]  

  • 15. Membrane associated antigens in chemically-induced tumours.
    Baldwin RW
    Ser Haematol; 1972; 5(4):67-92. PubMed ID: 4133764
    [No Abstract]   [Full Text] [Related]  

  • 16. In vivo and in vitro assays of cellular immunity to human tumor antigens.
    Herberman RB
    Fed Proc; 1973 Feb; 32(2):160-4. PubMed ID: 4120197
    [No Abstract]   [Full Text] [Related]  

  • 17. Analysis of inhibition of lymphocyte cytotoxicity in human colon carcinoma.
    Nind AP; Matthews N; Pihl EA; Rolland JM; Nairn RC
    Br J Cancer; 1975 Jun; 31(6):620-9. PubMed ID: 51647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum factors in tumor-free patients cancelling the blocking of cell-mediated tumor immunity.
    Hellström I; Hellström KE; Sjögren HO; Warner GA
    Int J Cancer; 1971 Sep; 8(2):185-91. PubMed ID: 4332366
    [No Abstract]   [Full Text] [Related]  

  • 19. Mediation of cytotoxic immune responses against human tumor-associated antigens by allogeneic immune RNA.
    Kern DH; Fritze D; Schick PM; Chow N; Pilch YH
    J Natl Cancer Inst; 1976 Jul; 57(1):105-9. PubMed ID: 1003493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte mediated cytotoxicity to tumor antigens.
    Hellström I; Hellström KE
    Johns Hopkins Med J Suppl; 1974; 3():37-50. PubMed ID: 4608238
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.